Patient-derived xenografts faithfully replicated clinical outcome in a phase II co-clinical trial of arsenic trioxide in relapsed small cell lung cancer

Phase II clinical trial of didemnin B in previously treated small cell lung cancer

Investigational New Drugs ◽

10.1007/bf00873966 ◽

1994 ◽

Vol 12 (3) ◽

pp. 243-249 ◽

Cited By ~ 26

Author(s):

Dong M. Shin ◽

Paul Y. Holoye ◽

Arthur Forman ◽

Rodger Winn ◽

Roman Perez-Soler ◽

...

Keyword(s):

Lung Cancer ◽

Clinical Trial ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Small Cell ◽

Phase Ii Clinical Trial ◽

Didemnin B ◽

Small Cell Lung ◽

Previously Treated

Abstract CT152: Phase II clinical trial results for 4-demethyl-4-cholesteryloxycarbonyl-penclomedine (DM-CHOC-PEN) in advanced non-small cell lung cancer (NSCLC) involving the CNS

10.1158/1538-7445.am2021-ct152 ◽

2021 ◽

Author(s):

Roy S. Weiner ◽

Lee Roy Morgan ◽

Marcus Ware ◽

Tallat Mahmood ◽

Craig Gordon ◽

...

Keyword(s):

Lung Cancer ◽

Clinical Trial ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Small Cell ◽

Phase Ii Clinical Trial ◽

Small Cell Lung ◽

Clinical Trial Results

Abstract 4664: Result of TORI L-03, a randomized, multicenter phase II clinical trial of erlotinib (E) or E + fulvestrant (F) in previously treated advanced non-small cell lung cancer (NSCLC).

10.1158/1538-7445.am2013-4664 ◽

2013 ◽

Cited By ~ 7

Author(s):

Edward B. Garon ◽

Jill M. Siegfried ◽

Steven M. Dubinett ◽

Robert M. Elashoff ◽

David J. Park ◽

...

Keyword(s):

Lung Cancer ◽

Clinical Trial ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Small Cell ◽

Phase Ii Clinical Trial ◽

Small Cell Lung ◽

Multicenter Phase ◽

Previously Treated

Tolerability of a combination of carboplatin and etoposide phosphate in elderly patients with small cell lung cancer. A multicentric phase II clinical trial

Lung Cancer ◽

10.1016/s0169-5002(00)80131-2 ◽

2000 ◽

Vol 29 (1) ◽

pp. 41 ◽

Cited By ~ 3

Author(s):

E Quoix ◽

J.L Breton ◽

C Daniel ◽

P Jacoulet ◽

D Debieuvre ◽

...

Keyword(s):

Lung Cancer ◽

Clinical Trial ◽

Elderly Patients ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Small Cell ◽

Phase Ii Clinical Trial ◽

Small Cell Lung ◽

Etoposide Phosphate

Phase II Clinical Trial of Lobaplatin (D-19466) in Pretreated Patients with Small-Cell Lung Cancer

Oncology Research and Treatment ◽

10.1159/000218823 ◽

1996 ◽

Vol 19 (4) ◽

pp. 328-332 ◽

Cited By ~ 6

Author(s):

H.H. Fiebig ◽

H. Henß ◽

I. von Pawel ◽

U. Gatzemeier ◽

Ch. Manegold ◽

...

Keyword(s):

Lung Cancer ◽

Clinical Trial ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Small Cell ◽

Phase Ii Clinical Trial ◽

Small Cell Lung ◽

Pretreated Patients

C-kit protein expression in tumor specimens as a predictor of sensitivity to imatinib mesylate in patients with small cell lung cancer (SCLC): A phase II clinical trial

10.1200/jco.2004.22.14_suppl.7218 ◽

2004 ◽

Vol 22 (14_suppl) ◽

pp. 7218-7218 ◽

Cited By ~ 1

Author(s):

L. M. Krug ◽

J. P. Crapanzano ◽

V. A. Miller ◽

C. G. Azzoli ◽

N. Rizvi ◽

...

Keyword(s):

Lung Cancer ◽

Clinical Trial ◽

Protein Expression ◽

Small Cell Lung Cancer ◽

Imatinib Mesylate ◽

Phase Ii ◽

Cell Lung Cancer ◽

Small Cell ◽

Phase Ii Clinical Trial ◽

A phase II clinical trial of gemcitabine and imatinib mesylate for patients with recurrent non-small cell lung cancer (NSCLC)

10.1200/jco.2008.26.15_suppl.19101 ◽

2008 ◽

Vol 26 (15_suppl) ◽

pp. 19101-19101

Author(s):

M. Eleff ◽

M. A. Sovak ◽

D. Greenberg ◽

L. Guensch ◽

P. Joyce ◽

...

Keyword(s):

Lung Cancer ◽

Clinical Trial ◽

Small Cell Lung Cancer ◽

Imatinib Mesylate ◽

Phase Ii ◽

Cell Lung Cancer ◽

Small Cell ◽

Phase Ii Clinical Trial ◽

A phase II, single-arm clinical trial involving an alternative cancer treatment psorinum therapy in patients with advanced non-small cell lung cancer (NSCLC).

10.1200/jco.2010.28.15_suppl.2592 ◽

2010 ◽

Vol 28 (15_suppl) ◽

pp. 2592-2592 ◽

Cited By ~ 2

Author(s):

A. Chatterjee ◽

J. Biswas ◽

A. K. Chatterjee ◽

S. Bhattacharya ◽

B. P. Mukhopadhyay ◽

...

Keyword(s):

Lung Cancer ◽

Clinical Trial ◽

Cancer Treatment ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Small Cell ◽

Phase II randomized clinical trial comparing immunotherapy plus stereotactic ablative radiotherapy (I-SABR) versus SABR alone for stage I, selected stage IIa or isolated lung parenchymal recurrent non-small cell lung cancer: I-SABR.

10.1200/jco.2018.36.15_suppl.tps8580 ◽

2018 ◽

Vol 36 (15_suppl) ◽

pp. TPS8580-TPS8580 ◽

Cited By ~ 4

Author(s):

Joe Y. Chang ◽

Lei Feng ◽

Steven H. Lin ◽

James William Welsh ◽

Mara Antonoff ◽

...

Keyword(s):

Lung Cancer ◽

Clinical Trial ◽

Small Cell Lung Cancer ◽

Randomized Clinical Trial ◽

Phase Ii ◽

Cell Lung Cancer ◽

Small Cell ◽

Stereotactic Ablative Radiotherapy ◽

Small Cell Lung ◽

Isolated Lung

P3-108: Correlative genomics in a phase II clinical trial of first-line therapy of erlotinib for clinically selected patients with advanced non-small cell lung cancer

Journal of Thoracic Oncology ◽

10.1097/01.jto.0000284084.26665.47 ◽

2007 ◽

Vol 2 (8) ◽

pp. S725

Author(s):

Janessa J. Laskin ◽

Trevor Pugh ◽

Lorena Barclay ◽

Margaret Sutcliffe ◽

Diana Ionescu ◽

...

Keyword(s):

Lung Cancer ◽

Clinical Trial ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Small Cell ◽

Small Cell Lung ◽

First Line ◽

First Line Therapy ◽

Line Therapy